Sangamo Therapeutics (SGMOQ) Share-based Compensation Growth (3y) (2013 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Share-based Compensation Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.13 Bn | 9.29 Bn | 112.79 Mn | 7.70% |
| 2 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn | -3.32% |
| 4 | Legend Biotech | 3.68 Bn | 2.72 Bn | 251.50 Mn | 3.61% |
| 5 | uniQure | 3.08 Bn | 3.08 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | -16.05% |
| 9 | Vericel | 2.00 Bn | 1.84 Bn | 56.40 Mn | 1.21% |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | -36.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -36.32% |
| Sep 30, 2025 | -35.13% |
| Jun 30, 2025 | -34.49% |
| Mar 31, 2025 | -30.37% |
| Dec 31, 2024 | -25.92% |
| Sep 30, 2024 | -25.05% |
| Jun 30, 2024 | -31.37% |
| Mar 31, 2024 | -28.77% |
| Dec 31, 2023 | -2.76% |
| Sep 30, 2023 | -2.52% |
| Jun 30, 2023 | 0.13% |
| Mar 31, 2023 | 13.77% |
| Sep 30, 2022 | -35.94% |
| Jun 30, 2022 | -35.62% |
| Mar 31, 2022 | 4.83% |
| Dec 31, 2021 | 23.35% |
| Sep 30, 2021 | 27.37% |
| Jun 30, 2021 | 39.22% |
| Mar 31, 2021 | -10.75% |
| Dec 31, 2020 | 46.33% |